Taromentin

GIF decision: Withdrawal from market, Marketing prohibition

What does this decision mean?

  • Wycofanie z obrotu — Some of the products covered by the decision were withdrawn from the market — please return them to the pharmacy/distributor.
  • Zakaz wprowadzania — Selected batches are subject to a marketing prohibition — the product cannot be distributed to pharmacies.

It was found that in the carton of Taromentin 1000 mg + 200 mg (batch 2010525) there was a vial of Taromentin 500 mg + 100 mg, containing half the dose of active substances, which may lead to insufficient therapeutic efficacy. Potential effects: lack of treatment efficacy, possible infection-related complications.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Taromentin
Risk Level
Critical
Manufacturer
Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A. z siedzibą w Warszawie
Batch Number
2010525
Notice Date
30.01.2026
View official statement

Related

Other Notices